News

RPG Life Sciences announced that the Board of Directors of the Company at its meeting held on 29 April 2026, inter alia, have recommended the final dividend of Rs 24 per equity Share (i.e. 300%) , subject to the approval of the shareholders.

Net profit of RPG Life Sciences declined 74.52% to Rs 29.90 crore in the quarter ended March 2026 as against Rs 117.35 crore during the previous quarter ended March 2025. Sales rose 23.62% to Rs 176.89 crore in the quarter ended March 2026 as against Rs 143.09 crore during the previous quarter ended March 2025.For the full year,net profit declined 37.15% to Rs 115.17 crore in the year ended March 2026 as against Rs 183.24 crore during the previous year ended March 2025. Sales rose 8.28% to Rs 707.52 crore in the year ended March 2026 as against Rs 653.43 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales176.89143.09 24 707.52653.43 8 OPM %18.5617.81 -20.7924.43 - PBDT44.8430.37 48 171.78171.71 0 PBT39.1025.00 56 150.30150.28 0 NP29.90117.35 -75 115.17183.24 -37 Powered by Capital Market - Live News

Net profit of RPG Life Sciences declined 36.64% to Rs 22.13 crore in the quarter ended December 2025 as against Rs 34.93 crore during the previous quarter ended December 2024. Sales rose 4.24% to Rs 180.03 crore in the quarter ended December 2025 as against Rs 172.71 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales180.03172.71 4 OPM %22.0928.46 - PBDT42.9252.35 -18 PBT37.5446.89 -20 NP22.1334.93 -37 Powered by Capital Market - Live News

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 27 January 2026.Powered by Capital Market - Live News

Net profit of RPG Life Sciences rose 777.38% to Rs 36.85 crore in the quarter ended September 2025 as against Rs 4.20 crore during the previous quarter ended September 2024. Sales rose 5.50% to Rs 181.68 crore in the quarter ended September 2025 as against Rs 172.21 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales181.68172.21 5 OPM %21.4826.67 - PBDT43.4547.70 -9 PBT38.2342.39 -10 NP36.854.20 777 Powered by Capital Market - Live News